FDA — authorised 29 December 1992
- Application: NDA020262
- Marketing authorisation holder: HQ SPCLT PHARMA
- Local brand name: TAXOL
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Taxol in United States
FDA authorised Taxol on 29 December 1992
Marketing authorisation
Taxol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Taxol approved in United States?
Yes. FDA authorised it on 29 December 1992.
Who is the marketing authorisation holder for Taxol in United States?
HQ SPCLT PHARMA holds the US marketing authorisation.